Skip to content
The Great News – Lifestyle
Home
Sample Page
Author:
AnaCardio
AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet
June 25, 2026